ERD

Sort by

European Partnerships

Show in overview

EU-Programme-Call

Show in overview

7 items found

Toggle all information

SAFIRE | SAFETY OF ANTIMALARIALS IN THE FIRST TRIMESTER: AN ADAPTIVE PLATFORM TRIAL

01-06-2024

30-11-2028

Show more information

Organisation UNIVERSITE DE KINSHASA

PYRAPREG-extended | Efficacy and Safety of a newly registered Artemisinin-Based Combination (Pyronaridine-Artesunate -PYRAMAX®) for the treatment of uncomplicated malaria in African pregnant women - Extended

01-05-2024

30-04-2025

Show more information

Organisation UNIVERSITE DE KINSHASA

ODIN | Strengthening Environmental Surveillance to Advance Public Health Action

01-07-2023

30-06-2026

Show more information

Organisation UNIVERSITE DE KINSHASA

EBOVAC3 | Bringing a prophylactic Ebola vaccine to licensure

01-06-2018

30-09-2024

Show more information

Organisation UNIVERSITE DE KINSHASA

ODIN-MPox | Implementing wastewater and environmental surveillance for Mpox in Sub-Saharan Africa

01-08-2024

31-07-2026

Show more information

Organisation UNIVERSITE DE KINSHASA

SEMA ReACT | SEvere MAlaria treatment with Rectal artesunate and Artemisinin-based Combination Therapy [in remote settings]

01-04-2023

31-03-2027

Show more information

Organisation UNIVERSITE DE KINSHASA

PregInPoxVac | MATERNAL AND INFANT SAFETY AND IMMUNOGENICITY IN A PHASE 3, OPEN-LABEL, RANDOMISED, VACCINE TRIAL OF A TWO-DOSE MPOX VACCINE

01-08-2024

31-07-2027

Show more information

Organisation UNIVERSITE DE KINSHASA

Projects overview

Selected filters:

SAFIRE | SAFETY OF ANTIMALARIALS IN THE FIRST TRIMESTER: AN ADAPTIVE PLATFORM TRIAL

PYRAPREG-extended | Efficacy and Safety of a newly registered Artemisinin-Based Combination (Pyronaridine-Artesunate -PYRAMAX®) for the treatment of uncomplicated malaria in African pregnant women - Extended

ODIN | Strengthening Environmental Surveillance to Advance Public Health Action

EBOVAC3 | Bringing a prophylactic Ebola vaccine to licensure

ODIN-MPox | Implementing wastewater and environmental surveillance for Mpox in Sub-Saharan Africa

SEMA ReACT | SEvere MAlaria treatment with Rectal artesunate and Artemisinin-based Combination Therapy [in remote settings]

PregInPoxVac | MATERNAL AND INFANT SAFETY AND IMMUNOGENICITY IN A PHASE 3, OPEN-LABEL, RANDOMISED, VACCINE TRIAL OF A TWO-DOSE MPOX VACCINE